NYU Langone Long Island Clinical Research Associates
Great Neck, New York, United States
Medical group in Manhasset, New York
1000 Northern Blvd, Great Neck, NY 11021
About NYU Langone Long Island Clinical Research Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
5
Shire
4
Galapagos NV
3
Celgene
2
Amgen
1
Bristol-Myers Squibb
1
Eli Lilly and Company
1
Gilead Sciences
1
Janssen Scientific Affairs, LLC
1
Takeda
1
Clinical Trials at NYU Langone Long Island Clinical Research Associates
During the past decade, NYU Langone Long Island Clinical Research Associates conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
2011-10-01
2015-03-01
Completed
280
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
2012-07-20
2016-05-27
Completed
593
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
2012-04-01
2015-05-01
Completed
614
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
2011-12-01
2014-12-01
Completed
121
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
2012-04-01
2016-07-01
Completed
150
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
2015-01-08
2019-06-03
Completed
170
A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease
2015-04-08
2017-12-14
Completed
64
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NYU Langone Long Island Clinical Research Associates" #1 sponsor was "Pfizer" with 5 trials, followed by "Shire" with 4 trials
sponsored, "Galapagos NV" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Langone Long Island Clinical Research Associates"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at NYU Langone Long Island Clinical Research Associates
According to Clinical.Site data, the most researched conditions in "NYU Langone Long Island Clinical Research Associates" are
"Crohn's Disease" (9 trials), "Ulcerative Colitis" (7 trials), "Crohn Disease" (3 trials), "Colitis, Ulcerative" (1 trials) and "Ulcerative Colitis and Crohn's Disease" (1 trials). Many other conditions were trialed in "NYU Langone Long Island Clinical Research Associates" in a lesser frequency.
Clinical Trials Intervention Types at NYU Langone Long Island Clinical Research Associates
Most popular intervention types in "NYU Langone Long Island Clinical Research Associates" are "Drug" (18 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Filgotinib" (4 trials), "CP-690,550" (3 trials), "Ontamalimab" (3 trials) and "GED-0301" (2 trials). Other intervention names were less common.
Clinical Trials Genders at NYU Langone Long Island Clinical Research Associates
The vast majority of trials in "NYU Langone Long Island Clinical Research Associates" are
20 trials for "All" genders.
Clinical Trials Status at NYU Langone Long Island Clinical Research Associates
Currently, there are NaN active trials in "NYU Langone Long Island Clinical Research Associates".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 13 completed trials in NYU Langone Long Island Clinical Research Associates,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in NYU Langone Long Island Clinical Research Associates, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".